UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 18, 2026
Accession Number:
0001493152-26-010114
Submission Type:
POS AM
CIK:
0001113423
Company Name:
COSCIENS Biopharma Inc.
File Number:
333-277115